文献速递心律失常

皮下与经静脉植入式心律转复除颤器不适当电击的个体参与者数据荟萃分析

Inappropriate Shocks From Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: Individual Participant Data Meta-Analysis of Randomized Trials.
PubMed 文献 · J Am Coll Cardiol · 2025-12-10

该研究基于PRAETORIAN和ATLAS两项随机试验的个体参与者数据,比较皮下与经静脉ICD首次不适当电击的发生率。汇总1,342例患者,中位随访3.5年,皮下ICD组首次不适当电击发生率更高(每100患者年2.5 vs 1.5;HR 1.61;95%CI 1.06-2.45;P=0.03),主要因心脏过感知和电磁干扰/肌电信号,而经静脉ICD因房性心律失常导致的不适当电击更多。

要点

  • 皮下ICD首次不适当电击发生率高于经静脉ICD(HR 1.61;95%CI 1.06-2.45;P=0.03)。
  • 皮下ICD因心脏过感知(HR 15.07)和电磁干扰/肌电信号(HR 8.19)导致的不适当电击风险更高。
  • 经静脉ICD因房性心律失常导致的不适当电击风险更高(HR 0.37,皮下vs经静脉)。

核心结论

  • 首次不适当电击总体不常见,但皮下ICD比经静脉ICD更常见。
  • 皮下ICD因心脏过感知和电磁干扰导致的不适当电击更多,经静脉ICD因房性心律失常导致的不适当电击更多。

研究设计与样本

  • PRAETORIAN和ATLAS随机试验的个体参与者数据荟萃分析,采用按试验分层的Cox回归模型。
  • 汇总改良意向治疗人群1,342例,中位年龄58岁,女性21.8%,77.7%为一级预防适应证。
  • 皮下ICD组中77.1%的患者在基线或随访期间激活了旨在减少不适当电击的专有算法。
  • 中位随访3.5年,主要终点为首次不适当电击时间。

主要发现

  • 首次不适当电击发生率:皮下ICD组每100患者年2.5次,经静脉ICD组每100患者年1.5次(HR 1.61;95%CI 1.06-2.45;P=0.03)。
  • 心脏过感知导致首次不适当电击:HR 15.07(95%CI 3.60-63.15;P<0.001),皮下ICD风险更高。
  • 电磁干扰或肌电信号导致首次不适当电击:HR 8.19(95%CI 1.88-35.64;P=0.005),皮下ICD风险更高。
  • 房性心律失常导致首次不适当电击:HR 0.37(95%CI 0.19-0.71;P=0.003),皮下ICD风险更低。

临床怎么用

  • 对于标准ICD适应证患者,选择皮下ICD时应考虑其较高的不适当电击风险,尤其是心脏过感知和电磁干扰相关电击。
  • 经静脉ICD患者需关注房性心律失常导致的不适当电击风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The PRAETORIAN (Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) and ATLAS (Avoid Transvenous Leads in Appropriate Subjects) trials demonstrated a reduction in lead-related complications with subcutaneous compared with transvenous implantable cardioverter-defibrillators (ICDs) in patients with standard ICD indications. However, they were not individually powered to assess differences in inappropriate shock. OBJECTIVES: The aims of this study were to compare the rates of a first inappropriate shock between subcutaneous and transvenous ICDs and to explore the underlying causes. METHODS: An individual participant data meta-analysis of PRAETORIAN and ATLAS was performed, using Cox regression models stratified by trial. The primary endpoint was time to first inappropriate shock. RESULTS: The pooled modified intention-to-treat population included 1,342 patients (median age 58 years, 21.8% women, 77.7% with primary prevention indications) who had been randomized to subcutaneous or transvenous ICDs. A proprietary algorithm aimed at reducing inappropriate shock was activated at baseline or at some point during follow-up in 77.1% of patients with subcutaneous ICDs. During a median follow-up period of 3.5 years, a first inappropriate shock occurred more frequently in patients randomized to subcutaneous compared with transvenous ICDs (2.5 vs 1.5 per 100 patient-years; HR: 1.61; 95% CI: 1.06-2.45; P = 0.03). Patients with subcutaneous ICDs had a higher hazard of first inappropriate shock due to cardiac oversensing (HR: 15.07; 95% CI: 3.60-63.15; P < 0.001) and electromagnetic interference or myopotentials (HR: 8.19; 95% CI: 1.88-35.64; P = 0.005) but a lower hazard of first inappropriate shock due to atrial arrhythmia (HR: 0.37; 95% CI: 0.19-0.71; P = 0.003). CONCLUSIONS: Although first inappropriate shocks were infrequent overall, they were more common with subcutaneous ICDs. First inappropriate shocks due to cardiac oversensing and electromagnetic interference were more common with subcutaneous ICDs, while first shocks due to atrial arrhythmia were more common with transvenous ICDs.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Benz AP, Olde Nordkamp LRA, McIntyre WF, et al. Inappropriate Shocks From Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: Individual Participant Data Meta-Analysis of Randomized Trials. J Am Coll Cardiol. 2025. PMID: 41369620. doi:10.1016/j.jacc.2025.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。